CollabRx, a CommerceNet portfolio company, was featured in “Twin Disorders,” an article in the November 2008 issue of The Scientist.

“CollabRx facilitates collaboration between researchers of Niemann-Pick Type C.

“The purpose is to find therapies faster by getting scientists to develop a targeted strategy for doing so, share ideas and data, and making sure no one doubles another’s efforts.

“CollabRx’s software platform lets them share data and ideas remotely.”

Access full article